Rethinking Drug Costs: Why Quick Fixes Might Hurt More Than Help

A New Prescription for Prosperity: US & UK Seal Zero-Tariff Pharma Deal

A Vital Step Forward: Sarepta's Duchenne Drug Secures Key Testing Clearance

A New Era for Drug Prices: How Medicare's Negotiation Power is Reshaping Healthcare

The Unfolding Saga of GLP-1 Drugs: A Potential Game-Changer for Alzheimer's?

The Evolving Landscape of Biotech Innovation and Investment

Wegovy's Reckoning: Novo Nordisk's CEO Digs In as the Weight Loss Market Heats Up

The Wegovy Paradox: Cheaper, Yet Still Out of Reach for Many

The Cost of Cures: Unraveling the High Price Tag on Biologic Drugs and the Persistent Push for Affordability

The Great Pharmaceutical Gridlock: How Patents Keep Prices Sky-High and Biosimilars at Bay

A Grand Bargain for Health? The Looming Question of Obesity Drugs and Who Pays.

The Great Negotiation: Big Pharma, Weight Loss, and the White House

The Ghost in the Machine: How Trump's Drug Price Transparency Memo Almost Changed Everything—But Didn't

The Astonishing Disparity: Why Miebo's Price Tag is a World Apart Across the Atlantic

The Quiet Revolution: How the FDA is Finally Taking Aim at Sky-High Drug Prices

Biotech's Pulse Check: AI Rises, a Cancer Test Stumbles, and a Rare Disease Shines

The Biotech Beat: Unpacking a Week of Breakthroughs, Billions, and Big Bets

Biotech's Pulse: Gene-Editing's Leap, Cancer's New Fights, and What's Stirring the Industry

The Shadow Returns: What Trump's Drug Pricing Encore Means for Your Medicine Cabinet

Trump Unleashes Trade Weapon Against Global Partners Over 'Unfair' Drug Prices

Biotech's Vanguard: Novo Nordisk, Omeros, and GSK Charting New Territories in Medical Innovation

AstraZeneca's Landmark Deal: Lowering Drug Prices for Medicaid Under Trump Administration Agreement

Revolutionizing Healthcare: Trump's Bold Stance on Lowering Prescription Drug Costs

President Trump's Landmark Initiative to Tackle Skyrocketing Prescription Drug Costs

Trump's Bold New Blueprint: Unveiling Ambitious Plans to Slash Prescription Drug Costs

Rethinking Drug Costs: Trump's Bold Bid to Reshape Pharmaceutical Pricing

White House Shelves Generic Drug Tariffs, Paving the Way for Indian Pharma's Continued Success

Trump's Pharma Tariffs: A Risky Gamble on American Innovation and Health

The Perilous Bargain: Are We Trading Future Cures for Today's Drug Savings?

Crucial Medicare Drug Price Loophole Fix Stalled: A Setback for Patient Savings

The Enduring Battle: Trump, Pfizer, and the Shifting Tides of Prescription Drug Pricing

TrumpRx Unveils Groundbreaking Platform to Dramatically Cut Prescription Drug Costs

Game Changer: Pfizer Secures Tariff Reprieve, Vows Lower Drug Prices for Millions of Americans

Pfizer's Bold New Chapter: Shares Soar as Pharma Giant Commits to Sweeping US Drug Price Cuts

Trump Hails Landmark Pfizer Deal: $70 Million US Investment and Drug Price Cuts Announced

Trump Hails "Historic" Deal with Pfizer to Drastically Cut Drug Prices

Trump's Bold Move: White House Pressures Pharma Giants for Lower Drug Prices

Trump's Landmark Drug Price Promise: A Deadline Vanished, Unnoticed

Trump's Bold Pharmaceutical Tariff Plan: Unpacking the 'America First' Drug Strategy